PHC Holdings Corp. (PHCCF)
8.91
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
PHC Holdings Research and Development Expense (Annual) : 72.43M for March 31, 2026
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 72.43M |
| March 31, 2025 | 70.36M |
| March 31, 2024 | 82.79M |
| March 31, 2023 | 73.28M |
| Date | Value |
|---|---|
| March 31, 2022 | 91.32M |
| March 31, 2021 | 148.12M |
| March 31, 2020 | 135.27M |
| March 31, 2019 | 118.99M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CellaVision AB | 8.875M |
| ALR Technologies SG Ltd. | -- |
| M3, Inc. | 0.00 |
| HealthStream, Inc. | 50.98M |
| Simulations Plus, Inc. (DELISTED) | 6.884M |